ID: ALA4639355

Max Phase: Preclinical

Molecular Formula: C17H15N3O3

Molecular Weight: 309.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cccc(-n2cc(COc3ccccc3)nn2)c1

Standard InChI:  InChI=1S/C17H15N3O3/c1-22-17(21)13-6-5-7-15(10-13)20-11-14(18-19-20)12-23-16-8-3-2-4-9-16/h2-11H,12H2,1H3

Standard InChI Key:  JIKZXQNNTHXCBQ-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 309.32Molecular Weight (Monoisotopic): 309.1113AlogP: 2.63#Rotatable Bonds: 5
Polar Surface Area: 66.24Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: -1.78

References

1. Kronenberger T, Ferreira GM, de Souza ADF, da Silva Santos S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise-Filho R..  (2020)  Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors.,  28  (15): [PMID:32631571] [10.1016/j.bmc.2020.115600]

Source